Smart Melphalan Formulation Management System

Publication ID: 24-11857677_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Smart Melphalan Formulation Management System,” Published Technical Disclosure No. 24-11857677_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857677_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,677.

Summary of the Inventive Concept

A comprehensive system integrating melphalan injectable formulations with cutting-edge technologies like AI, IoT, blockchain, and wearables to ensure stability, optimize storage, and personalize treatment.

Background and Problem Solved

The original patent addressed the need for stable and ready-to-use injectable formulations of melphalan. However, the existing solutions lack real-time monitoring, automated optimization, and personalized treatment. This inventive concept tackles these limitations by incorporating synergistic technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The Smart Melphalan Formulation Management System consists of multiple components: (1) a sensor-enabled injectable formulation that detects degradation and alerts users; (2) an AI-driven processor that analyzes environmental data and predicts optimal storage conditions; (3) a blockchain-based ledger for tracking and verifying authenticity and integrity; (4) a wearable device for monitoring treatment efficacy; and (5) an AI-powered dosing regimen predictor. These components interact seamlessly to ensure the stability, efficacy, and personalization of melphalan injectable formulations.

Novelty and Inventive Step

The inventive concept's novelty lies in the synergistic integration of distinct technologies to create a comprehensive system that addresses the limitations of existing melphalan formulations. The inventive step is the combination of these technologies to provide real-time monitoring, automated optimization, and personalized treatment, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of sensors, AI algorithms, or blockchain platforms. Variations could involve integrating the system with electronic health records or using machine learning to predict patient responses to different dosing regimens.

Potential Commercial Applications and Market

The Smart Melphalan Formulation Management System has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of cancer treatment, personalized medicine, and supply chain management.

CPC Classifications

SectionClassGroup
A A61 A61K9/08
A A61 A61K9/0019
A A61 A61K31/198
A A61 A61K47/10
A A61 A61K47/183
A A61 A61K47/32

Original Patent Information

Patent NumberUS 11,857,677
TitleReady to use injectable formulations of melphalan and processes for preparation thereof
Assignee(s)RK PHARMA INC.